Aceragen, Inc. of EXTON, PA filed a DEFA14A with the SEC on 2022-09-28. Industry: Biological Products, (No Diagnostic Substances).
Showing 15 of 30 documents.
| Seq | Type | Description |
|---|---|---|
| 1 | DEFA14A | DEFA14A |
| 2 | EX-99.1 | EXHIBIT 99.1 |
| 3 | EX-99.2 | EXHIBIT 99.2 |
| 4 | GRAPHIC | GRAPHIC |
| 5 | GRAPHIC | GRAPHIC |
| 6 | GRAPHIC | GRAPHIC |
| 7 | GRAPHIC | GRAPHIC |
| 8 | GRAPHIC | GRAPHIC |
| 9 | GRAPHIC | GRAPHIC |
| 10 | GRAPHIC | GRAPHIC |
| 11 | GRAPHIC | GRAPHIC |
| 12 | GRAPHIC | GRAPHIC |
| 13 | GRAPHIC | GRAPHIC |
| 14 | GRAPHIC | GRAPHIC |
| 15 | GRAPHIC | GRAPHIC |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2023-07-21 | DEF 14A |
| 2023-07-11 | PRE 14A |
| 2023-07-11 | DEFA14A |
| 2022-12-08 | DEF 14A |
| 2022-11-18 | PRE 14A |
| 2022-09-30 | DEFA14A |
| 2022-09-28 | DEFA14A |
| 2022-04-29 | DEFA14A |
| 2022-04-29 | DEF 14A |
| 2021-04-28 | DEFA14A |
| 2021-04-28 | DEF 14A |
| 2020-05-01 | DEFA14A |